Computational drug discovery: Exploring natural products targeting SARS-CoV-2
The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...
Phase 2 trial reveals potential of DPP-1 inhibitor for bronchiectasis
The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...
News-Medical.Net on MSN11d
Natural compounds identified as potential inhibitors of SARS-CoV-2 spike protein
Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...
Verywell Health on MSN38m
Contrave vs. Wegovy: How Do They Compare for Weight Loss?
Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...
Mirage News11d
Natural Products Target Covid in Drug Discovery
The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...
L-Arginine: What Men Should Know Before Starting It
Chances are, if you think you (ED), you’ve already looked into dietary supplements — and pretty much any option other than ...
Artificial cells can glow at room temperature in response to external target molecules
Cell-free systems, which can express an easily detectable protein with a DNA or mRNA template without constraints of living ...
Fierce Pharma3d
Sanofi's versatile Qfitlia scores FDA nod to enter crowded hemophilia market
Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...